New Rise Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 129.70%
- Profit Growth -173.49%
- Ebitda 191.96%
- Net Worth -758.69%
- Total Assets -55.48%
About New Rise Life Science
New Rise Life Science Private Limited (NRLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2020 (Five years 20 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Umadevi Muvva and Narasimhareddy Vanipenta serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24129TG2020PTC138968
- Company No.
138968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at New Rise Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umadevi Muvva  | Director | 01-Dec-2023 | Current |
| Narasimhareddy Vanipenta | Director | 01-Dec-2023 | Current |
Financial Performance of New Rise Life Science.
New Rise Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 129.7% increase. The company also saw a substantial fall in profitability, with a 173.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 758.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Rise Life Science?
Unlock access to New Rise Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at New Rise Life Science?
Unlock and access historical data on people associated with New Rise Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Rise Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Rise Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
